Literature DB >> 7686896

Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve.

K U Loeffler1, D P Edward, M O Tso.   

Abstract

PURPOSE: To characterize the constituents of corpora amylacea in the human retina and optic nerve.
METHODS: Immunohistochemistry was performed on sections of retina, optic nerve, and brain tissue using antibodies against tau 1, tau-2, and amyloid precursor protein.
RESULTS: Consistent anti-tau-2 immunoreactivity was noted in the corpora amylacea in the retina, optic nerve, and brain tissue, albeit with variations in pattern and intensity of staining. No immunoreactivity was observed with antibodies anti-tau 1 and anti-amyloid precursor protein.
CONCLUSION: Our findings suggest the accumulation of possibly abnormal tau-2 within the corpora amylacea, which may be either astrocytic or axonal in origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686896

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.

Authors:  He Meng; Xiaojie Zhang; Mila Blaivas; Michael M Wang
Journal:  Neuropathology       Date:  2009-04-28       Impact factor: 1.906

2.  Spinal corpora amylacea and motor neuron disease: a quantitative study.

Authors:  J B Cavanagh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

3.  Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain.

Authors:  Ryan J Day; Maria J Mason; Chloe Thomas; Wayne W Poon; Troy T Rohn
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

4.  Reelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer's disease patients.

Authors:  Tina Notter; Irene Knuesel
Journal:  Acta Neuropathol Commun       Date:  2013-06-26       Impact factor: 7.801

5.  New perspectives on corpora amylacea in the human brain.

Authors:  Elisabet Augé; Itsaso Cabezón; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

Review 6.  Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases.

Authors:  Mohammad Amir Mishan; Mozhgan Rezaei Kanavi; Koorosh Shahpasand; Hamid Ahmadieh
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24

7.  Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?

Authors:  Troy T Rohn
Journal:  Int J Neurol Neurother       Date:  2015-08-28

8.  Exploring the elusive composition of corpora amylacea of human brain.

Authors:  Elisabet Augé; Jordi Duran; Joan J Guinovart; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.